-

Leading CDMO Adopts ValGenesis to Support Robotic Manufacturing Expansion

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc. today announced that a leading fill-finish contract development and manufacturing organization (CDMO) specializing in sterile filling has adopted ValGenesis to modernize logbook management across its state-of-the-art manufacturing facilities.

The application scales to support thousands of users across multiple global sites and offers offline functionality for secure, controlled environments, ensuring continuous, compliant operations as the company grows.

Share

As the company expanded operations to include advanced robotic manufacturing lines and increasingly sophisticated equipment, managing hundreds of paper logbooks became inefficient and difficult to scale. By implementing ValGenesis, the company has eliminated the limitations of manual record-keeping, enabling real-time data capture, automated compliance checks, and seamless traceability.

The cloud-based electronic logbook application is designed to meet the rigorous requirements of the life sciences industry. It enables users to digitally capture, track, and maintain GMP logbooks across multiple devices. The application scales to support thousands of users across multiple global sites and offers offline functionality for secure, controlled environments, ensuring continuous, compliant operations as the company grows.

By strengthening its quality management system and optimizing resource utilization, the company ensures that collected data adheres to ALCOA+ data integrity principles while accelerating time to market for its clients.

“We’re excited to support this customer in their digital transformation journey,” said Steve Reynolds, chief revenue officer at ValGenesis. “By replacing paper-based logbooks with ValGenesis, the company is strengthening compliance, improving operational efficiency, and ensuring scalability as it continues to grow and adopt advanced manufacturing technologies.”

About ValGenesis Inc.

ValGenesis, Inc. is the global leader in enterprise digital validation. Serving the life sciences industry for nearly two decades, ValGenesis enables companies to digitize their commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP™ Platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers worldwide reduce costs, improve compliance, and accelerate innovation. For more information, visit https://www.valgenesis.com/.

Contacts

Further information

Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 althea.dsylva@valgenesis.com

ValGenesis, Inc.


Release Versions

Contacts

Further information

Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 althea.dsylva@valgenesis.com

Social Media Profiles
More News From ValGenesis, Inc.

Eugia Pharmaceuticals Goes Live with ValGenesis to Modernize CSV

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the leader in enterprise digital validation, announced that Eugia Pharmaceuticals, a global specialty pharmaceutical company, has gone live with ValGenesis to modernize computer system validation (CSV) processes across its sites in India. The deployment will help enhance compliance, improve operational efficiency, and support growth. Hyderabad-based Eugia Pharma, a subsidiary of Aurobindo Pharma, develops and markets complex generics. The...

ValGenesis to Host ValConnect Mumbai Focused on AI-Driven Validation

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the leader in digital validation, will host ValConnect Innovation Day on Sept. 9 at the Hilton Mumbai International Airport, bringing together leaders from life sciences, technology, and manufacturing to examine the role of AI in validation, compliance, and quality across the GxP lifecycle. The one-day event, which concludes the 2026 ValConnect Innovation Day series, will focus on a central challenge facing life sciences organizations: how...

Leading Oncology Injectables Manufacturer Selects ValGenesis to Modernize Equipment Qualification

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the global leader in enterprise digital validation and compliance solutions, announced that a specialized Indian pharmaceutical joint venture focused on cytotoxic and oncology drug manufacturing, has selected the ValGenesis validation lifecycle management platform to modernize equipment qualification across its operations in India. The company manufactures injectable and sterile products for regulated global markets, operating state-of-the-...
Back to Newsroom